Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018

Ann Intern Med. 2018 May 1;168(9):640-650. doi: 10.7326/M18-0222. Epub 2018 Apr 3.

Abstract

Description: The American Diabetes Association (ADA) annually updates its Standards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and management of patients with diabetes.

Methods: For the 2018 standards, the ADA Professional Practice Committee searched MEDLINE through November 2017 to add, clarify, or revise recommendations on the basis of new evidence. The committee rated the recommendations as A, B, or C depending on the quality of evidence or E for expert consensus or clinical experience. The standards were reviewed and approved by the Executive Committee of the ADA Board of Directors, which includes health care professionals, scientists, and laypersons. Feedback from the larger clinical community informed revisions.

Recommendations: This synopsis focuses on guidance relating to cardiovascular disease and risk management in nonpregnant adults with diabetes. Recommendations address diagnosis and treatment of cardiovascular risk factors (hypertension and dyslipidemia), aspirin use, screening for and treatment of coronary heart disease, and lifestyle interventions.

Publication types

  • Practice Guideline

MeSH terms

  • Adult
  • Antihypertensive Agents / therapeutic use
  • Aspirin / therapeutic use
  • Blood Pressure Monitoring, Ambulatory
  • Coronary Disease / diagnosis
  • Coronary Disease / prevention & control*
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / therapy*
  • Diabetic Angiopathies / prevention & control*
  • Dyslipidemias / diagnosis
  • Dyslipidemias / prevention & control*
  • Healthy Lifestyle
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypertension / diagnosis
  • Hypertension / prevention & control*
  • Hypoglycemic Agents / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use
  • Risk Factors
  • Risk Management
  • Standard of Care*

Substances

  • Antihypertensive Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypoglycemic Agents
  • Platelet Aggregation Inhibitors
  • Aspirin